Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
The promoting effects of ascorbic acid, sodium erythorbate and ethoxyquin on two-stage urinary bladder carcinogenesis in F344 rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) at a dose of 0.05% in the drinking water were examined. Administration of 5% sodium erythorbate in the diet significantly increased the incidences of preneoplastic lesions, papilloma and cancer of the urinary bladder, whereas administration of 5% ascorbic acid in the diet did not. Administration of 0.8% ethoxyquin also increased the incidence of neoplastic lesions. Administrations of 5% sodium L-ascorbate and 5% sodium erythorbate caused increases in the pH, the sodium content and crystals of MgNH4PO4 in the urine. These results show that sodium erythorbate and ethoxyquin promote urinary bladder carcinogenesis, while ascorbic acid does not.
D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology* / Q000652:urine; D001835:Body Weight / Q000187:drug effects; D002085:Butylhydroxybutylnitrosamine / Q000633:toxicity*; D002273:Carcinogens; D003043:Cocarcinogenesis; D004573:Electrolytes / Q000652:urine; D005015:Ethoxyquin / Q000494:pharmacology* / Q000652:urine; D006863:Hydrogen-Ion Concentration; D006965:Hyperplasia / Q000139:chemically induced; D008297:Male; D009602:Nitrosamines / Q000633:toxicity*; D009929:Organ Size / Q000187:drug effects; D009994:Osmolar Concentration; D010212:Papilloma / Q000139:chemically induced*; D011804:Quinolines / Q000494:pharmacology*; D051381:Rats; D001743:Urinary Bladder / Q000187:drug effects / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced*
D002273:Carcinogens; D004573:Electrolytes; D009602:Nitrosamines; D011804:Quinolines; C005056:isoascorbic acid; D002085:Butylhydroxybutylnitrosamine; D005015:Ethoxyquin; D001205:Ascorbic Acid